Jane Street’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-346,900
| Closed | -$10.3M | – | 10413 |
|
|
2023
Q4 | $10.3M | Sell |
346,900
-205,300
| -37% | -$4.09M | ﹤0.01% | 1916 |
|
|
2023
Q3 | $8.76M | Buy |
552,200
+198,300
| +56% | +$3.3M | ﹤0.01% | 1928 |
|
|
2023
Q2 | $6.68M | Buy |
353,900
+310,400
| +714% | +$3.66M | ﹤0.01% | 2359 |
|
|
2023
Q1 | $167K | Buy |
+43,500
| New | +$185K | ﹤0.01% | 7955 |
|
|
2022
Q4 | – | Sell |
-10,100
| Closed | -$48K | – | 10433 |
|
|
2022
Q3 | $48K | Sell |
10,100
-6,500
| -39% | -$34.3K | ﹤0.01% | 8953 |
|
|
2022
Q2 | $75K | Sell |
16,600
-33,900
| -67% | -$147K | ﹤0.01% | 8784 |
|
|
2022
Q1 | $240K | Sell |
50,500
-5,500
| -10% | -$30.5K | ﹤0.01% | 8760 |
|
|
2021
Q4 | $416K | Buy |
56,000
+29,600
| +112% | +$184K | ﹤0.01% | 7583 |
|
|
2021
Q3 | $150K | Buy |
26,400
+3,900
| +17% | +$22.5K | ﹤0.01% | 9063 |
|
|
2021
Q2 | $148K | Sell |
22,500
-4,200
| -16% | -$29.3K | ﹤0.01% | 9054 |
|
|
2021
Q1 | $216K | Buy |
26,700
+1,500
| +6% | +$12.2K | ﹤0.01% | 8166 |
|
|
2020
Q4 | $163K | Buy |
+25,200
| New | +$147K | ﹤0.01% | 7046 |
|
|
2018
Q3 | – | Sell |
-35,500
| Closed | -$345K | – | 5856 |
|
|
2018
Q2 | $345K | Buy |
+35,500
| New | +$374K | ﹤0.01% | 3982 |
|
|
2018
Q1 | – | Sell |
-10,000
| Closed | -$64K | – | 5566 |
|
|
2017
Q4 | $64K | Buy |
+10,000
| New | +$61.7K | ﹤0.01% | 4399 |
|
Other funds holding IMGN
Jane Street's IMGN Position: Q1 2024 in Review
Jane Street sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 634,353 shares — an estimated $18.8M sold.
Jane Street first reported a position in IMGN in Q2 2013 and held it in 29 quarters. The position peaked at $18.8M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Jane Street reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Jane Street sold 634,353 Immunogen Inc shares in Q1 2024, an estimated $18.8M.
- Jane Street first reported a position in Immunogen Inc in Q2 2013 and held it in 29 quarters.
- Jane Street's Immunogen Inc position peaked at $18.8M in Q4 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.